Collectively, we have shown that ISX, BRD4, and PCAF are co‐expressed in liver cells, and the expression of the ISX–BRD4 complex plays a significant role in determining the prognosis of patients with HCC. This evidence concerns the gene KAT2B and hepatocellular carcinoma.